Literature DB >> 16217095

Coxibs and cardiovascular risk.

Syed A H Zaidi.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16217095      PMCID： PMC1247684          DOI： 10.1503/cmaj.1050143

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  New restrictions on celecoxib (Celebrex) use and the withdrawal of valdecoxib (Bextra).

Authors:  Jill Cotter; Eric Wooltorton
Journal:  CMAJ       Date:  2005-04-15       Impact factor: 8.262

Review 2.  Risk of cardiovascular events associated with selective COX-2 inhibitors.

Authors:  D Mukherjee; S E Nissen; E J Topol
Journal:  JAMA       Date:  2001 Aug 22-29       Impact factor: 56.272

3.  Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages.

Authors:  C S Baker; R J Hall; T J Evans; A Pomerance; J Maclouf; C Creminon; M H Yacoub; J M Polak
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

4.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors:  C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

5.  Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions.

Authors:  U Schönbeck; G K Sukhova; P Graber; S Coulter; P Libby
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 6.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Authors:  Roberto Bolli; Ken Shinmura; Xian-Liang Tang; Eitaro Kodani; Yu-Ting Xuan; Yiru Guo; Buddhadeb Dawn
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

7.  Evidence for ozone formation in human atherosclerotic arteries.

Authors:  Paul Wentworth; Jorge Nieva; Cindy Takeuchi; Roger Galve; Anita D Wentworth; Ralph B Dilley; Giacomo A DeLaria; Alan Saven; Bernard M Babior; Kim D Janda; Albert Eschenmoser; Richard A Lerner
Journal:  Science       Date:  2003-11-07       Impact factor: 47.728
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.